[PHARMA] QoQ Cumulative Quarter Result on 31-Dec-2012 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
18-Feb-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Dec-2012 [#4]
Profit Trend
QoQ- -11.39%
YoY- 18.32%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Revenue 1,378,779 937,972 500,339 1,812,346 1,329,942 903,482 446,745 111.83%
PBT 59,990 46,529 36,924 103,313 99,066 70,573 42,955 24.91%
Tax -24,496 -15,205 -11,771 -40,108 -28,392 -25,435 -13,894 45.89%
NP 35,494 31,324 25,153 63,205 70,674 45,138 29,061 14.24%
-
NP to SH 34,387 30,636 24,771 61,710 69,645 44,398 28,685 12.83%
-
Tax Rate 40.83% 32.68% 31.88% 38.82% 28.66% 36.04% 32.35% -
Total Cost 1,343,285 906,648 475,186 1,749,141 1,259,268 858,344 417,684 117.72%
-
Net Worth 473,857 481,681 484,829 471,886 496,623 481,282 474,161 -0.04%
Dividend
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Div 25,427 17,661 8,825 41,187 29,420 17,650 8,824 102.36%
Div Payout % 73.95% 57.65% 35.63% 66.74% 42.24% 39.76% 30.76% -
Equity
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Net Worth 473,857 481,681 484,829 471,886 496,623 481,282 474,161 -0.04%
NOSH 258,938 258,968 117,676 117,677 117,683 117,672 117,657 69.11%
Ratio Analysis
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
NP Margin 2.57% 3.34% 5.03% 3.49% 5.31% 5.00% 6.51% -
ROE 7.26% 6.36% 5.11% 13.08% 14.02% 9.22% 6.05% -
Per Share
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
RPS 532.47 362.20 425.18 1,540.10 1,130.10 767.79 379.70 25.26%
EPS 13.28 11.83 21.05 52.44 59.18 37.73 24.38 -33.27%
DPS 9.82 6.82 7.50 35.00 25.00 15.00 7.50 19.66%
NAPS 1.83 1.86 4.12 4.01 4.22 4.09 4.03 -40.89%
Adjusted Per Share Value based on latest NOSH - 117,715
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
RPS 95.67 65.08 34.72 125.75 92.28 62.69 31.00 111.82%
EPS 2.39 2.13 1.72 4.28 4.83 3.08 1.99 12.97%
DPS 1.76 1.23 0.61 2.86 2.04 1.22 0.61 102.53%
NAPS 0.3288 0.3342 0.3364 0.3274 0.3446 0.3339 0.329 -0.04%
Price Multiplier on Financial Quarter End Date
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Date 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 -
Price 4.82 4.49 8.26 8.10 7.55 10.18 5.90 -
P/RPS 0.91 1.24 1.94 0.53 0.67 1.33 1.55 -29.86%
P/EPS 36.30 37.95 39.24 15.45 12.76 26.98 24.20 31.00%
EY 2.76 2.63 2.55 6.47 7.84 3.71 4.13 -23.54%
DY 2.04 1.52 0.91 4.32 3.31 1.47 1.27 37.11%
P/NAPS 2.63 2.41 2.00 2.02 1.79 2.49 1.46 47.99%
Price Multiplier on Announcement Date
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Date 19/11/13 16/08/13 15/05/13 18/02/13 06/11/12 08/08/12 03/05/12 -
Price 4.72 4.66 9.26 7.80 8.25 8.83 5.90 -
P/RPS 0.89 1.29 2.18 0.51 0.73 1.15 1.55 -30.89%
P/EPS 35.54 39.39 43.99 14.87 13.94 23.40 24.20 29.17%
EY 2.81 2.54 2.27 6.72 7.17 4.27 4.13 -22.62%
DY 2.08 1.46 0.81 4.49 3.03 1.70 1.27 38.90%
P/NAPS 2.58 2.51 2.25 1.95 1.95 2.16 1.46 46.11%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment